Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2011 059 952.6 |
| 96 | EP file number | EAKZ | 15 19 4057.4 |
| 97 | EP publication number | EPN | 3009442 |
| 54 | Designation/title | TI | KRISTALLINE FORMEN EINES MAKROLIDS UND VERWENDUNGEN DAFÜR |
| 51 | IPC main class | ICM
(ICMV) | C07H 17/08 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/7048 (2006.01), C07D 498/04 (2006.01), A61P 31/00 (2006.01), A61P 31/04 (2006.01) |
| 22 | DE application date | DAT | Mar 22, 2011 |
| 96 | EP application date | EAT | Mar 22, 2011 |
| 43 | Date of first publication | OT | Apr 20, 2016 |
| Date of publication of grant | PET | Jun 19, 2019 |
| 71/73 | Applicant/owner | INH | Cempra Pharmaceuticals, Inc., Morristown, NJ, US |
| 72 | Inventor | IN | Pereira, David, Apex, NC 27502, US |
| Address for service | | Withers & Rogers LLP, London SE1 2AU, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
316063 P
Mar 22, 2010
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003009442
Searchable text:
EP000003009442
Original document:
EP000003009442B1
Searchable text:
EP000003009442B1 |
| 43 | Date of first publication | EVT | Apr 20, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Jun 3, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 25, 2020
(Show all update days)(Hide all update days)- Dec 25, 2020; Nov 17, 2020; Aug 5, 2020; Jul 23, 2020; Sep 17, 2019; Aug 19, 2019; Jul 11, 2019; Jun 1, 2019; May 30, 2019; Jul 20, 2017
- Historical data not available for this/these date(s)
- Jun 3, 2016
- Date of the first transfer into DPMAregister
|
